Nos communiqués
de presse

Angels Santé welcomes Fortrea as a new corporate member

Angels Santé welcomes Fortrea as a new corporate member

May 2024 – Angels Santé is delighted to announce the addition of Fortrea, a leading global provider of clinical development solutions, to its network of corporate members.

Fortrea’s extensive expertise and innovative approach in the life sciences industry make them an invaluable partner for our network and portfolio companies.

Fortrea is renowned for its collaboration with biotech firms, large biopharmaceutical companies, and medical device and diagnostic companies, driving healthcare innovation and accelerating the delivery of life-changing therapies to patients. This partnership aligns perfectly with Angels Santé’s mission to support early-stage biotech companies in their growth and development.

Fortrea provides comprehensive phase I-IV clinical trial management, clinical pharmacology, and consulting solutions for Regulatory, Product Development strategy, Health Economics and Outcomes Research (HEOR), and Market Access. Additionally, their Real-World Evidence (RWE) Advisory and Research services further enhance their capability to deliver impactful solutions.

With over 30 years of experience across more than 20 therapeutic areas, Fortrea’s team of 19,000 professionals operates in over 90 countries, providing focused and agile solutions to customers worldwide. Their global reach and diverse expertise are instrumental in supporting the international clinical and strategic development of biotech companies.

“Fortrea’s global experience and outstanding reputation are a real asset for us as we continuously seek to support our companies in their international clinical and strategic development,” says Eric Garnier, President of Angels Santé. “We are thrilled to welcome Fortrea to our network and look forward to the mutual benefits this partnership will bring.”

The French Team of Fortrea shares their enthusiasm: “Our mission is to communicate effectively, understand the needs of biotech companies, and provide precise expertise at the right moment. By joining Angels Santé, we are closer to young biotech companies, enabling us to assess their needs early on and transform science into new drugs, making a profound difference in the lives of patients.”

For more information about Angels Santé , please contact:

For more information about Fortrea, please contact

Angélique Boutet-Mary ,

Veronique Charrier,

About Angels Santé

Angels Santé is Europe’s leading business angel network specializing in life sciences. With a diverse group of investors, we provide strategic support and funding to early-stage biotech, medtech and digital health companies, fostering innovation and growth in the healthcare sector.

About Fortrea

Fortrea is a global provider of clinical development solutions, partnering

with biotech and biopharmaceutical companies to drive healthcare innovation. With over three decades of experience, Fortrea delivers comprehensive solutions in clinical trial management, regulatory consulting, and real-world evidence services, operating in more than 90 countries.